INS and type 2 diabetes mellitus: Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) are widely recognized as complementary agents in strategies for T2DM remission, largely due to their potential to improve insulin sensitivity.